
HPLC Verified
Research Grade
COA Published
Tirzepatide 30mg
Tirzepatide
CAS: 2023788-19-2
Dual GLP-1/GIP receptor agonist. 99.2% purity. 30mg two-dose supply; SURMOUNT-1 −20.9% at 72 weeks; supports back-to-back protocol cycles without interruption.
Price
$249.99
30 in stock
HPLC verified · third-party tested · research use only
Specifications
Tirzepatide — Research Overview
Dual GLP-1/GIP receptor agonist. 99.2% purity. 30mg two-dose supply; SURMOUNT-1 −20.9% at 72 weeks; supports back-to-back protocol cycles without interruption.
Related Products

Semaglutide 3mg
Semaglutide
GLP-1 receptor agonist. 99.1% purity. Starter 3mg vial suited to initial dose-titration research; STEP-1 trial recorded −14.9% mean body weight at 68 weeks.
$49.99
CAS 910463-68-2

Semaglutide 6mg
Semaglutide
GLP-1 receptor agonist. 99.1% purity. Mid-range 6mg vial supports two-vial titration schedules; STEP-1 Phase 3 mean weight reduction −14.9% over 68 weeks.
$79.99
CAS 910463-68-2
Tirzepatide 30mg
$249.99

